We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVCM:NASDAQEverCommerce Inc. Analysis

Data as of 2026-04-01 - not real-time

$11.49

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

EverCommerce is trading at $11.49, comfortably above its 20‑day SMA (11.26) and 50‑day SMA (11.19) but still below the 200‑day SMA (10.99), indicating a short‑term bullish bias within a longer‑term uptrend. Technical indicators are supportive – the MACD histogram is positive (0.077) and the signal is bullish, while the RSI sits at a neutral 53, suggesting room for upside without immediate over‑extension. The stock sits between a clear support level at $9.06 and resistance near $12.74, with the current price only ~4.9% below the DCF‑derived fair value of $4.13, highlighting a substantial valuation premium. Fundamentally, the company posted $588.9 M in revenue with 5.2% YoY growth, strong gross margins (77.6%) and modest operating margins (8.4%), yet its trailing PE of 115 dwarfs the industry average of 33, and forward PE of 14.9 still reflects a high price relative to earnings. Recent earnings missed consensus EPS ($0.033 vs $0.045 expected), but revenue beat and a $44.2 M adjusted EBITDA for Q4 signal operational resilience. The firm is investing heavily in AI‑driven product launches, which management cites as a catalyst for the $612‑$632 M 2026 revenue target, but the balance sheet carries $541.9 M of debt and a debt‑to‑equity ratio of 75.6, raising leverage concerns. Volatility remains elevated at 77% over the past 30 days, and a beta of ~1.05 suggests market‑aligned risk. Overall, the stock’s upside is limited by its overvalued pricing, earnings miss, and debt load, while upside potential hinges on successful AI roll‑outs and sustained revenue growth.
Investors should therefore weigh the strong cash flow generation and high margins against the premium valuation and execution risk. The current technical backdrop is bullish, but the fundamental disconnect between price and intrinsic value warrants a cautious stance, especially in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical indicators (MACD, SMA alignment)
  • Recent earnings miss versus expectations
  • Significant valuation premium to DCF and peers

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • AI product launches driving revenue expansion
  • Forward PE compression toward 14.9
  • Stable operating cash flow and high margins

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistently high valuation relative to fundamentals
  • Elevated leverage and debt‑to‑equity ratio
  • Sector‑specific competitive and regulatory dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin2.99%
P/E Ratio114.9
ROE2.48%
ROA2.68%
Debt/Equity75.59
P/B Ratio2.9
Op. Cash Flow$111.5M
Free Cash Flow$68.7M
Industry P/E33.3

Technical Analysis

TrendBullish
RSI53.0
Support$9.06
Resistance$12.74
MA 20$11.26
MA 50$11.19
MA 200$10.99
MACDBullish
VolumeStable
Fear & Greed Index77.59

Valuation

Fair Value$4.13
Target Price$10.93
Upside/Downside-4.89%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.05
Volatility77.19%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.